SlideShare a Scribd company logo
1 of 66
LIPID PROFILE
INTRODUCTION ,[object Object]
IMPORTANCE of LIPIDS ,[object Object],[object Object],[object Object],[object Object],[object Object]
CLASSIFICATION OF LIPIDS LIPIDS SIMPLE LIPIDS DERIVED LIPIDS FATS WAXES COMPOUND LIPIDS PHOSPHO LIPIDS CEREBROSIDES SULFO LIPIDS FATTY  ACIDS STEROIDS
 
LIPOPROTEINS ,[object Object],[object Object],[object Object]
LIPOPROTEINS-CLASSIFICATION LIPOPROTEINS MAJOR LIPOPROTEINS MINOR/ABNORMAL LIPOPROTEINS CHYLOMICRONS V.L.D.L L.D.L H.D.L I.D.L Lp (a) Lp X Beta – V.L.D.L
PLASMA LIPOPROTEINS 1.063-1.125 HDL 2 5 Beta 0-12 1.019-1.063 180-300 A LDL 4 Beta OR Pre-Beta 12-20 1.006-1.019 IDL 3 PRE-Beta 20-400 0.95-1.006 300-700 A VLDL 2 ORIGIN >400 < 0.95 750-12,000 A CHYLOMICRONS 1 MOBILITY Sf DENSITY(Kg/L) DIAMETER TYPE
PLASMA LIPOPROTEINS PRE-Beta 1.045-1.080 Lp (a) 7 ORIGIN >400 1.125-1.210 50-20 A HDL 3 6 MOBILITY Sf DENSITY(Kg/L) DIAMETER TYPE
PLASMA LIPOPROTEINS 26-32 2-7 15-20 3-5 45-55 HDL 18-24 4-8 45-50 6-8 18-22 LDL 15-20 45-65 16-22 4-8 6-10 VLDL 3-6 80-95 2-4 1-3 1-2 CHYLOMICRON PL % TG % Ch. ESTERS % CHOLESTEROL % PROTEIN % LIPOPROTEIN
APOLIPOPROTEINS ,[object Object],[object Object],[object Object]
MAJOR APOLIPOPROTEINS Structural protein for chylomicrons Chylomicrons Intestine Apo-B48 Unknown VLDL Liver Apo-AV Unknown  HDL,Chylomicrons Intestine, Apo-AIV Structural protein for hdl HDL,Chylomicrons Liver Apo-AII Structural protein for hdl, activates LCAT HDL,Chylomicrons Intestine, Liver Apo-AI Function  Lipoprotein association Source  Apolipo- protein
MAJOR APOLIPOPROTEINS Unknown HDL Spleen,brain, Testes, adrenal Apo-D Inhibits lipoprotein binding to receptiors Chylomicrons,VLDL,HDL Liver Apo-CIII Cofactor for LPL Chylomicrons,VLDL,HDL Liver Apo-CII Unknown Chylomicrons,VLDL,HDL Liver Apo-CI Structural protein for VLDL,LDL,IDL,Lp(a) VLDL,IDL,LDL,Lp(a) Liver Apo-B100 Function  Lipoprotein association Source  Apolipo- protein
MAJOR APOLIPOPROTEINS Unknown Lp(a) Liver Apo-(a) Unknown Chylomicrons,VLDL,HDL Unknown Apo-L Unknown Chylomicrons,VLDL,HDL Liver Apo-J B2 glycoprotein Chylomicrons,VLDL,LDL,HDL Liver Apo-H Ligand for binding to LDL receptor Chylomicrons remnants,IDL,HDL Liver Apo-E Function  Lipoprotein association Source  Apolipo- protein
LIPID PROFILE TESTS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
INDICATIONS ,[object Object],[object Object],[object Object]
BLOOD SAMPLING & STORAGE ,[object Object],[object Object]
BLOOD SAMPLING & STORAGE ,[object Object],[object Object],[object Object],[object Object],[object Object]
BLOOD SAMPLING & STORAGE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
BLOOD SAMPLING & STORAGE ,[object Object],[object Object]
BLOOD SAMPLING & STORAGE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
BLOOD SAMPLING & STORAGE ,[object Object],[object Object],[object Object],[object Object]
BLOOD SAMPLING & STORAGE ,[object Object],[object Object],[object Object],[object Object]
BLOOD SAMPLING & STORAGE ,[object Object],[object Object],[object Object],[object Object]
BLOOD SAMPLING & STORAGE ,[object Object],[object Object],[object Object]
BLOOD SAMPLING & STORAGE ,[object Object],[object Object],[object Object],[object Object]
BLOOD SAMPLING & STORAGE ,[object Object],[object Object],[object Object]
BLOOD SAMPLING & STORAGE ,[object Object],[object Object],[object Object]
BLOOD SAMPLING & STORAGE ,[object Object],[object Object],[object Object],[object Object]
BLOOD SAMPLING & STORAGE ,[object Object],[object Object],[object Object]
BLOOD SAMPLING & STORAGE ,[object Object],[object Object],[object Object]
BLOOD SAMPLING & STORAGE ,[object Object],[object Object],[object Object],[object Object]
BLOOD SAMPLING & STORAGE ,[object Object],[object Object],[object Object],[object Object]
BLOOD SAMPLING & STORAGE ,[object Object],[object Object],[object Object],[object Object]
BLOOD SAMPLING & STORAGE ,[object Object],[object Object],[object Object],[object Object],[object Object]
ESTIMATION OF PLASMA LIPIDS ,[object Object]
CHOLESTEROL – chemical method ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
CHOLESTEROL –  enzymatic method ,[object Object]
CHOLESTEROL –  enzymatic method ,[object Object],[object Object],[object Object],[object Object],[object Object]
CHOLESTEROL –  enzymatic method ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
CHOLESTEROL –  enzymatic method ,[object Object],[object Object],[object Object],[object Object]
CHOLESTEROL –  enzymatic method ,[object Object],[object Object],[object Object],[object Object]
SERUM CHOLESTEROL: INCREASED IN  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
SERUM CHOLESTEROL: DECREASED IN ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
TRIGLYCERIDE-ENZYMATIC METHOD ,[object Object],[object Object],[object Object],[object Object],[object Object]
TRIGLYCERIDE: INCREASED IN  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
TRIGLYCERIDE: DECREASED IN ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
TRIGLYCERIDE ,[object Object],[object Object],> 5000 mg/dl 1)Hyper lipidemia type I or IV  2)Substantial risk of pancreatitis > 1000 mg/dl High risk of pancreatitis > 500 mg/dl Peri vascular disease 250-500 mg/dl No disease < 150 mg/dl Condition   Concentration of TG
HDL-CHOLESTEROL: HOMOGENOUS ASSAY ,[object Object],[object Object]
HDL-CHOLESTEROL: INCREASED IN ,[object Object],[object Object],[object Object]
HDL-CHOLESTEROL: DECREASED IN ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
LDL-CHOLESTEROL ,[object Object],[object Object],[object Object]
LDL-CHOLESTEROL ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
LDL-CHOLESTEROL: INCREASED IN ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
LDL-CHOLESTEROL: DECREASED IN ,[object Object],[object Object],[object Object]
VLDL-C/ PLASMA TG ratio ,[object Object],[object Object],[object Object],[object Object],[object Object]
NORMAL LEVELS 8.0-11.0 MG/DL PHOSPHOLIPID PHOSPHORUS 6 9.0-15.0 MMOL/L FREE FATTY ACIDS 5 150-380 MG/DL PHOSPHOLIPIDS 4 10-90 MG/DL TRIGLYCERIDES 3 150-250 MG/DL TOTAL CHOLESTEROL 2 400-800 MG/DL TOTAL LIPIDS 1 level lipid S.No
SERUM CHOLESTEROL & TG RISK CATEGORIES > or = 500 > or = 190 > 6.0 > 11.0 > or = 240 < 40 HIGH RISK 200-499 > or = 160 3.0-6.0 7.1-11.0 200-239 MODERATE RISK 150-199 < or = 130 4.4-7.1 AVERAGE RISK < 150 < 30 < 100 0.5-3.0 3.3-4.4 150- 250 > Or = 50 NORMAL SERUM-TG VLDL-C LDL-C LDL/HDL TC/HDL-C TC HDL-C RISK CAT.
CARDIAC RISK RATIO ,[object Object],[object Object],[object Object],[object Object]
MAJOR RISK FACTORS THAT MODIFY LDL GOALS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ATHEROGENIC INDEX ,[object Object],[object Object],[object Object]
ESTIMATION OF LIPOPROTEINS  ,[object Object],[object Object],[object Object],[object Object]
LIPOPROTEIN ELECTROPHORESIS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
COMPLICATIONS OF HYPERLIPIDEMIA ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
REFERENCES ,[object Object],[object Object]
[object Object]

More Related Content

What's hot

PANCREATIC FUNCTION TESTS
PANCREATIC FUNCTION TESTSPANCREATIC FUNCTION TESTS
PANCREATIC FUNCTION TESTS
YESANNA
 

What's hot (20)

Serum Protein and Albumin-Globulin Ratio
Serum Protein and Albumin-Globulin RatioSerum Protein and Albumin-Globulin Ratio
Serum Protein and Albumin-Globulin Ratio
 
Gastric function test 2
Gastric function test 2Gastric function test 2
Gastric function test 2
 
Lipid profile test ppt
Lipid profile test pptLipid profile test ppt
Lipid profile test ppt
 
PANCREATIC FUNCTION TESTS
PANCREATIC FUNCTION TESTSPANCREATIC FUNCTION TESTS
PANCREATIC FUNCTION TESTS
 
Glycated haemoglobin ppt by Basalingappa BG
Glycated haemoglobin ppt by Basalingappa BGGlycated haemoglobin ppt by Basalingappa BG
Glycated haemoglobin ppt by Basalingappa BG
 
Estimation of serum triglycerides by Dr. Tehmas
Estimation of serum triglycerides by Dr. TehmasEstimation of serum triglycerides by Dr. Tehmas
Estimation of serum triglycerides by Dr. Tehmas
 
Estimation of Serum Cholesterol and HDL
Estimation of Serum Cholesterol and HDLEstimation of Serum Cholesterol and HDL
Estimation of Serum Cholesterol and HDL
 
Glucose estimation
Glucose estimationGlucose estimation
Glucose estimation
 
Estimation of serum albumin by Dr.Tehmas
Estimation of serum albumin by Dr.TehmasEstimation of serum albumin by Dr.Tehmas
Estimation of serum albumin by Dr.Tehmas
 
LIVER FUNCTION TESTS (LFT)
LIVER FUNCTION TESTS (LFT)LIVER FUNCTION TESTS (LFT)
LIVER FUNCTION TESTS (LFT)
 
Lipid profile
Lipid profileLipid profile
Lipid profile
 
CLINICAL CHEMISTRY ELECTROLYTES
CLINICAL CHEMISTRY ELECTROLYTESCLINICAL CHEMISTRY ELECTROLYTES
CLINICAL CHEMISTRY ELECTROLYTES
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
 
creatinine clearance test
creatinine clearance testcreatinine clearance test
creatinine clearance test
 
Lipid profile tests by Pragya Pandey
Lipid  profile tests by Pragya PandeyLipid  profile tests by Pragya Pandey
Lipid profile tests by Pragya Pandey
 
Estimation of serum total protein
Estimation of serum total proteinEstimation of serum total protein
Estimation of serum total protein
 
Cholesterol practical pdf
Cholesterol practical pdfCholesterol practical pdf
Cholesterol practical pdf
 
Estimation of serum urea
Estimation of serum ureaEstimation of serum urea
Estimation of serum urea
 
Lipid profile
Lipid profile Lipid profile
Lipid profile
 
urea, creatinine,inulin clearance test.pptx
urea, creatinine,inulin clearance test.pptxurea, creatinine,inulin clearance test.pptx
urea, creatinine,inulin clearance test.pptx
 

Similar to Dr ravi lipid profile

Abetalipoprotienemia..Final..group 3
Abetalipoprotienemia..Final..group 3Abetalipoprotienemia..Final..group 3
Abetalipoprotienemia..Final..group 3
MD Specialclass
 
antihyper lipidemia & plantcons
antihyper lipidemia & plantconsantihyper lipidemia & plantcons
antihyper lipidemia & plantcons
Sasmita Saha
 
Ch 9 Lipid2 (1).ppt
Ch 9 Lipid2 (1).pptCh 9 Lipid2 (1).ppt
Ch 9 Lipid2 (1).ppt
WG WG
 
lipid_metabolism.ppt
lipid_metabolism.pptlipid_metabolism.ppt
lipid_metabolism.ppt
AdminVFFR
 
lipid_metabolism.ppt
lipid_metabolism.pptlipid_metabolism.ppt
lipid_metabolism.ppt
WG WG
 
Focus on high density lipoproteins
Focus on high density lipoproteinsFocus on high density lipoproteins
Focus on high density lipoproteins
Sachin Verma
 

Similar to Dr ravi lipid profile (20)

lipids & dyslipoproteinemia
 lipids & dyslipoproteinemia lipids & dyslipoproteinemia
lipids & dyslipoproteinemia
 
Ch 9 Lipid2.ppt
Ch 9 Lipid2.pptCh 9 Lipid2.ppt
Ch 9 Lipid2.ppt
 
Lipid transport 2020
Lipid transport 2020Lipid transport 2020
Lipid transport 2020
 
Abetalipoprotienemia..Final..group 3
Abetalipoprotienemia..Final..group 3Abetalipoprotienemia..Final..group 3
Abetalipoprotienemia..Final..group 3
 
CHOLESTEROL METHODS.pptx
CHOLESTEROL METHODS.pptxCHOLESTEROL METHODS.pptx
CHOLESTEROL METHODS.pptx
 
antihyper lipidemia & plantcons
antihyper lipidemia & plantconsantihyper lipidemia & plantcons
antihyper lipidemia & plantcons
 
Dyslipidaemia
DyslipidaemiaDyslipidaemia
Dyslipidaemia
 
Lipids methodology
Lipids methodologyLipids methodology
Lipids methodology
 
Estimation of serum cholesterol
Estimation of serum cholesterolEstimation of serum cholesterol
Estimation of serum cholesterol
 
Dyslipidemia and Atherosclerosis
Dyslipidemia and AtherosclerosisDyslipidemia and Atherosclerosis
Dyslipidemia and Atherosclerosis
 
Lipo proteins
Lipo proteinsLipo proteins
Lipo proteins
 
Ch 9 Lipid2 (1).ppt
Ch 9 Lipid2 (1).pptCh 9 Lipid2 (1).ppt
Ch 9 Lipid2 (1).ppt
 
Lipo proteins 2
Lipo proteins 2Lipo proteins 2
Lipo proteins 2
 
lipid_metabolism.ppt
lipid_metabolism.pptlipid_metabolism.ppt
lipid_metabolism.ppt
 
lipid_metabolism.ppt
lipid_metabolism.pptlipid_metabolism.ppt
lipid_metabolism.ppt
 
lipid_metabolism.ppt
lipid_metabolism.pptlipid_metabolism.ppt
lipid_metabolism.ppt
 
lipoprotein metabolism.pptx HDL METABOLISM, LDL METABOLIS, VLDL METABOLIS, C...
lipoprotein metabolism.pptx  HDL METABOLISM, LDL METABOLIS, VLDL METABOLIS, C...lipoprotein metabolism.pptx  HDL METABOLISM, LDL METABOLIS, VLDL METABOLIS, C...
lipoprotein metabolism.pptx HDL METABOLISM, LDL METABOLIS, VLDL METABOLIS, C...
 
Vbspu prabhakar singh first sem_ biochem unit iii_ lipids
Vbspu prabhakar singh first sem_ biochem unit iii_ lipidsVbspu prabhakar singh first sem_ biochem unit iii_ lipids
Vbspu prabhakar singh first sem_ biochem unit iii_ lipids
 
Lipopprotein by kk sahu
Lipopprotein by kk sahuLipopprotein by kk sahu
Lipopprotein by kk sahu
 
Focus on high density lipoproteins
Focus on high density lipoproteinsFocus on high density lipoproteins
Focus on high density lipoproteins
 

Recently uploaded

Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
claviclebrown44
 
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
ocean4396
 
In Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait City
In Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait CityIn Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait City
In Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait City
Abortion pills in Kuwait Cytotec pills in Kuwait
 

Recently uploaded (20)

5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)
 
Our Hottest 💘 Surat ℂall Girls Serviℂe 💘Pasodara📱 8527049040📱450+ ℂall Girl C...
Our Hottest 💘 Surat ℂall Girls Serviℂe 💘Pasodara📱 8527049040📱450+ ℂall Girl C...Our Hottest 💘 Surat ℂall Girls Serviℂe 💘Pasodara📱 8527049040📱450+ ℂall Girl C...
Our Hottest 💘 Surat ℂall Girls Serviℂe 💘Pasodara📱 8527049040📱450+ ℂall Girl C...
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
 
Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifier
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of action
 
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...
Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...
Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...
 
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
 
Premium ℂall Girls In Mumbai Airport👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa ...
Premium ℂall Girls In Mumbai Airport👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa ...Premium ℂall Girls In Mumbai Airport👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa ...
Premium ℂall Girls In Mumbai Airport👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa ...
 
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in children
 
Dermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdfDermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdf
 
VVIP Yelahanka ℂall Girls 6350482085 Heat-immolating { Bangalore } Coveted Gi...
VVIP Yelahanka ℂall Girls 6350482085 Heat-immolating { Bangalore } Coveted Gi...VVIP Yelahanka ℂall Girls 6350482085 Heat-immolating { Bangalore } Coveted Gi...
VVIP Yelahanka ℂall Girls 6350482085 Heat-immolating { Bangalore } Coveted Gi...
 
In Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait City
In Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait CityIn Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait City
In Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait City
 

Dr ravi lipid profile

  • 2.
  • 3.
  • 4. CLASSIFICATION OF LIPIDS LIPIDS SIMPLE LIPIDS DERIVED LIPIDS FATS WAXES COMPOUND LIPIDS PHOSPHO LIPIDS CEREBROSIDES SULFO LIPIDS FATTY ACIDS STEROIDS
  • 5.  
  • 6.
  • 7. LIPOPROTEINS-CLASSIFICATION LIPOPROTEINS MAJOR LIPOPROTEINS MINOR/ABNORMAL LIPOPROTEINS CHYLOMICRONS V.L.D.L L.D.L H.D.L I.D.L Lp (a) Lp X Beta – V.L.D.L
  • 8. PLASMA LIPOPROTEINS 1.063-1.125 HDL 2 5 Beta 0-12 1.019-1.063 180-300 A LDL 4 Beta OR Pre-Beta 12-20 1.006-1.019 IDL 3 PRE-Beta 20-400 0.95-1.006 300-700 A VLDL 2 ORIGIN >400 < 0.95 750-12,000 A CHYLOMICRONS 1 MOBILITY Sf DENSITY(Kg/L) DIAMETER TYPE
  • 9. PLASMA LIPOPROTEINS PRE-Beta 1.045-1.080 Lp (a) 7 ORIGIN >400 1.125-1.210 50-20 A HDL 3 6 MOBILITY Sf DENSITY(Kg/L) DIAMETER TYPE
  • 10. PLASMA LIPOPROTEINS 26-32 2-7 15-20 3-5 45-55 HDL 18-24 4-8 45-50 6-8 18-22 LDL 15-20 45-65 16-22 4-8 6-10 VLDL 3-6 80-95 2-4 1-3 1-2 CHYLOMICRON PL % TG % Ch. ESTERS % CHOLESTEROL % PROTEIN % LIPOPROTEIN
  • 11.
  • 12. MAJOR APOLIPOPROTEINS Structural protein for chylomicrons Chylomicrons Intestine Apo-B48 Unknown VLDL Liver Apo-AV Unknown HDL,Chylomicrons Intestine, Apo-AIV Structural protein for hdl HDL,Chylomicrons Liver Apo-AII Structural protein for hdl, activates LCAT HDL,Chylomicrons Intestine, Liver Apo-AI Function Lipoprotein association Source Apolipo- protein
  • 13. MAJOR APOLIPOPROTEINS Unknown HDL Spleen,brain, Testes, adrenal Apo-D Inhibits lipoprotein binding to receptiors Chylomicrons,VLDL,HDL Liver Apo-CIII Cofactor for LPL Chylomicrons,VLDL,HDL Liver Apo-CII Unknown Chylomicrons,VLDL,HDL Liver Apo-CI Structural protein for VLDL,LDL,IDL,Lp(a) VLDL,IDL,LDL,Lp(a) Liver Apo-B100 Function Lipoprotein association Source Apolipo- protein
  • 14. MAJOR APOLIPOPROTEINS Unknown Lp(a) Liver Apo-(a) Unknown Chylomicrons,VLDL,HDL Unknown Apo-L Unknown Chylomicrons,VLDL,HDL Liver Apo-J B2 glycoprotein Chylomicrons,VLDL,LDL,HDL Liver Apo-H Ligand for binding to LDL receptor Chylomicrons remnants,IDL,HDL Liver Apo-E Function Lipoprotein association Source Apolipo- protein
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40.
  • 41.
  • 42.
  • 43.
  • 44.
  • 45.
  • 46.
  • 47.
  • 48.
  • 49.
  • 50.
  • 51.
  • 52.
  • 53.
  • 54.
  • 55.
  • 56.
  • 57. NORMAL LEVELS 8.0-11.0 MG/DL PHOSPHOLIPID PHOSPHORUS 6 9.0-15.0 MMOL/L FREE FATTY ACIDS 5 150-380 MG/DL PHOSPHOLIPIDS 4 10-90 MG/DL TRIGLYCERIDES 3 150-250 MG/DL TOTAL CHOLESTEROL 2 400-800 MG/DL TOTAL LIPIDS 1 level lipid S.No
  • 58. SERUM CHOLESTEROL & TG RISK CATEGORIES > or = 500 > or = 190 > 6.0 > 11.0 > or = 240 < 40 HIGH RISK 200-499 > or = 160 3.0-6.0 7.1-11.0 200-239 MODERATE RISK 150-199 < or = 130 4.4-7.1 AVERAGE RISK < 150 < 30 < 100 0.5-3.0 3.3-4.4 150- 250 > Or = 50 NORMAL SERUM-TG VLDL-C LDL-C LDL/HDL TC/HDL-C TC HDL-C RISK CAT.
  • 59.
  • 60.
  • 61.
  • 62.
  • 63.
  • 64.
  • 65.
  • 66.